Today: February 6, 2016, 9:47 pm
  
Business

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress

PR-Inside.com: 2014-09-04 16:27:01

Dr. Dallabrida recognized for driving innovation in patient-driven eData technologies that improve clinical research

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress

For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com

PHT Corporation announced that Vice President of Clinical Science and Consulting Services Dr. Susan Dallabrida will present “Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma” at the ESMO 2014 Congress, 26-30 September in Madrid. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.

The ESMO 2014 Congress is sponsored by the European Society for Medical Oncology, the leading European professional organisation representing medical oncologists.

The poster abstract will also be published in the ESMO 2014 Congress Abstract Book, a supplement to the official ESMO journal Annals of Oncology.

The poster was developed by members of the PHT Clinical Science Team, with 100+ years of collective experience in ePROs and COAs:

  • Susan M. Dallabrida PhD, Vice President, Clinical Science & Consulting – Dr. Dallabrida has over 21 years of experience as a senior scientist, consultant and leader in clinical research and development, trial design and strategy, and product development. She has significant regulatory experience for biologics and small molecules.
  • Sarah Tressel Gary PhD, Senior Science Advisor – Dr. Gary has significant experience working with PRO development and validation studies, questionnaire design and working with developers of standardized instruments. She is experienced in migration studies including cognitive debriefing and usability testing in a number of therapeutic areas.

Learn more about the PHT Clinical Science Team: http://bit.ly/PHTCSC

Learn about the Effective Use, Analysis, and Best [..] in a new educational webinar, 10 September. Register here: http://www.phtcorp.com/About/News-Events/Upcoming-.

About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 17+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
www.pr-inside.com/



# 882 Words
Related Articles
 
More From Business
Nerium International Skin Care Independent Brand Partners [..]
Nerium was formed through the “accidental discovery” by Nerium Biotechnology Inc., an international research and development company, [..]
First Compliance Verification Process for Ethernet ECUs
RUETZ SYSTEM SOLUTIONS - experts in automotive data communication - provides the first compliance verification process for Ethernet [..]
Buckinghamshire Floor Sander Announces Extraordinary Growth [..]
Wood Floor People are a floor sanding and restoration Company based in Buckinghamshire and serve the surrounding counties of [..]
Let me introduce to you: your new [..]
The concept of a business center has become very popular and common the past few years - for a good [..]
Pipe forming and bending technology for mobile [..]
In the field of mobile construction machines, custom-fit pipes and reliable connections are much in demand for the safe use [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.